Return to Publications  |  Return to CINJ Home
The Cancer Institute of New Jersey's Cancer Connection, July 2012

Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center

 

 

Celebrating Community Partnerships to Protect Men's Health

 

PRAB Event

The Cancer Institute of New Jersey (CINJ) and Robert Wood Johnson University Hospital recently celebrated their ongoing success with the annual prostate cancer screening event along with PRAB and the Mt. Zion Church in New Brunswick. Last year, the annual screening led to 700 men being tested - the largest number of men screened during the event's history. Recently, community dignitaries, local clergy and civic leaders gathered at PRAB to acknowledge the milestone and were given special recognition for their dedication to educating their respective communities about the event. This year's free prostate cancer screening is scheduled for September 18 - 20 at CINJ. Call 1-888-MD-RWJUH for an appointment or visit the CINJ website for additional information.

Annual Charity Cycling Event Pedals Toward a Cure

 

Century for the Cure 2012

For the eighth year in a row, cycling enthusiasts and volunteers are being called upon to help pedal for a cure in the Century for the Cure bicycle ride to benefit The Cancer Institute of New Jersey. Each year, participants gather for this inspirational event with the common goal of eradicating cancer, one mile at a time. The September 8 event begins and ends at Camp Riverbend in Warren Township, with courses trailing through the scenic back roads of central New Jersey. The ride offers 100-mile, 80-mile, and 40-mile cycling options from which to choose. A "virtual rider" option is also available, allowing non-riders to support the cause without physically participating in the ride.Read more

Clinical Trial at CINJ Studies Vaccine and Hormone Therapy Combo for Prostate Cancer

 

prostate cancer vaccine

Investigators at CINJ have partnered with the National Cancer Institute and launched a clinical trial examining the effectiveness of a combined experimental vaccine known as PROSTVAC VF and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan. Researchers will compare these effects to those in patients who are receiving hormone therapy alone. The aim is to use the body's own T-cells - a type of white blood cell that plays a key role in the body's natural defenses in fighting off disease - as a means to directly target prostate cancer.Read more

 
RWJMS logo    CINJ logo        NCI logo 

CINJ Office of Communications  ·  195 Little Albany Street  ·  New Brunswick, NJ  ·  732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List